elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Communities
Lab
API & MCP
Pricing
Log in
Sign up
Home
/
Subjects
/
NAD+ kinase
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
NAD+ kinase
RIS
0.002
(Research Intensity Score)
Papers
162
Top papers
Mitochondrial complex I ROS production and redox signaling in hypoxia
2023 · 294 citations
A druggable copper-signalling pathway that drives inflammation
2023 · 337 citations
Reactive oxygen species in biological systems: Pathways, associated diseases, and potential inhibitors—A review
2023 · 190 citations
Membrane Damage during Ferroptosis Is Caused by Oxidation of Phospholipids Catalyzed by the Oxidoreductases POR and CYB5R1
2020 · 619 citations
Glycerol 3-phosphate dehydrogenases (1 and 2) in cancer and other diseases
2024 · 77 citations
Newest papers
Copper supports regulatory T cell energetic state to sustain peripheral immune tolerance
2026 · 5 citations
Unique Metal–Ligand Proton Tautomerism Underlying the Reversible Electrocatalytic NAD + /NADH Interconversion
2026 · 3 citations
Viral reprogramming of neuronal metabolism captured by label-free imaging in a 3D human brain tissue model
2026
Lactylation of GRP78 regulate Cx43 hemichannel activity to suppress accelerated follicular atresia in premature ovarian insufficiency
2026
Iridium and Ruthenium Complexes Bearing Uracil-Functionalized N-Heterocyclic Carbenes: Synthesis and Catalytic Activity in the Reduction of NAD +
2026
A sample from the 100 top papers behind NAD+ kinase.
Create a free account to browse them all →
NAD+ kinase's history
Research intensity over time
Explore NAD+ kinase's full history
Hover any year for its value and switch resolutions with a free account. Personal adds monthly detail and the historical-intensity (HRI) line.
Create a free account
Already have an account?
Log in
to explore the data.
Close ✕
NAD+ kinase's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link